To diagnose an AML with flow cytometric analysis, tumor cells should express one or more of the myeloid-associated antigens (CD11b, CD11c, CD14, or CD4 without CD3 or CD5) (2, 3, 9–13, 16). Here, CD5 is linked to acute myeloid leukemia.